BPC-157, a stable 15-amino-acid pentadecapeptide derived from a fragment of human gastric juice protein BPC, has been characterised in published research for its effects on angiogenesis, growth-factor signalling and connective-tissue repair across a wide range of injury models
Lets make sure we look at whats proven and safe first. Weight loss discussions are common, given that GLP1 receptor agonists often lead to reduced appetite and weight change
The metabolic hypothesis the earliest and still the most widely cited attributes most downstream benefits to reduced caloric intake and improved insulin sensitivity
Karimi, M., Pirzad, S., Hooshmand, F., Shirsalimi, N., & Pourfaraji, S